Tag Archives: XLE

Top High Tech Stocks To Watch Right Now

Let’s face it, when you’re hot, everyone wants a piece of you. That’s how a lot of companies feel as they decide to take their companies public. But, does it pay off for you, the investor? Well, sometimes, but first you have to be able to get the shares. For example, Snap, Inc. trading under the ticker SNAP, priced its 200 million share public offering yesterday at $17 a share, became completely oversubscribed, and today is trading at a 40 percent premium. 

Monitors display Snap Inc. signage on the floor of the New York Stock Exchange (NYSE) during the company’s initial public offering (IPO) in New York, U.S., on Thursday, March 2, 2017. Michael Nagle/Bloomberg

What strategies can you consider if you’re eyeing that company going public soon?

Top High Tech Stocks To Watch Right Now: Helmerich & Payne, Inc.(HP)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Helmerich & Payne alerts:

    YieldBoost Helmerich & Payne From 4.2% To 8.4% Using Options (nasdaq.com) HP Stock Crowded With Sellers (nasdaq.com) Helmerich & Payne – In Need Of A Better Profit Margin (seekingalpha.com) Crude Oil Futures: Drivers on June 4–8 (finance.yahoo.com) Brokerages Expect Helmerich & Payne, Inc. (HP) Will Announce Quarterly Sales of $614.29 Million (americanbankingnews.com)

    A number of equities research analysts have issued reports on the stock. ValuEngine upgraded shares of Helmerich & Payne from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd. Zacks Investment Research cut shares of Helmerich & Payne from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. TheStreet cut shares of Helmerich & Payne from a “b-” rating to a “c” rating in a report on Thursday, April 26th. Credit Suisse Group upped their price objective on shares of Helmerich & Payne from $51.00 to $63.00 and gave the company a “market perform” rating in a research report on Friday, April 27th. Finally, Susquehanna Bancshares raised shares of Helmerich & Payne from a “neutral” rating to a “positive” rating and upped their price objective for the company from $42.16 to $75.00 in a research report on Friday, March 9th. Five analysts have rated the stock with a sell rating, sixteen have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $58.42.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Helmerich & Payne (HP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Brookstone Capital Management lowered its position in shares of Helmerich & Payne, Inc. (NYSE:HP) by 21.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 75,802 shares of the oil and gas company’s stock after selling 20,141 shares during the quarter. Brookstone Capital Management’s holdings in Helmerich & Payne were worth $4,833,000 as of its most recent SEC filing.

  • [By Garrett Baldwin]

    On Tuesday, the Trump administration said it would press ahead with 25% tariffs on roughly $50 billion in Chinese goods. As U.S. Trade Secretary Wilbur Ross prepares to head to Beijing to discuss trade this week, the Trump administration is demanding that China address ongoing theft of U.S. intellectual property.
    Ahead of Friday’s jobs report, Automatic Data Processing (NYSE: ADP) reported that private jobs increased by 178,000 during May. That figure was actually 12,000 behind what the markets were anticipating. Job growth appears to be slowing down as the firm also revised its jobs figure for April downward, from 204,000 new positions to 163,000.
    Three Stocks to Watch Today: KORS, HP, KMI
    Michael Kors Holdings Ltd. (NYSE: KORS) stock was off 3.2% in pre-market hours after the company reported earnings before the bell. The luxury retailer reported earnings per share (EPS) of $0.63, a figure that topped Wall Street expectations of $0.60. The firm also beat revenue expectations and reported an increase in same-store sales. However, the firm’s earnings forecast for the year ahead came in lower than expectations, a factor that pushed its stock lower on Wednesday morning.
    Shares of HP Inc. (NYSE: HP) were up slightly after the company raised its full-year outlook and topped Wall Street earnings expectations on Tuesday. The company cited stronger demand in desktops and notebooks for its financial performance. The firm matched EPS expectations of $0.48. However, revenue came in at $14.0 billion, a figure that easily beat forecasts of $13.59.
    The Canadian government announced plans to purchase the Trans Mountain pipeline from Kinder Morgan Canada Ltd. (NYSE: KML) for $3.5 billion. The Canadian government said that the deal was the only way to ensure that the long-awaited project could proceed. The pipeline runs from the Alberta oil sands to a port all the way in British Columbia along the Pacific Ocean. The pipeline is designed to give Canadian crude grea

Top High Tech Stocks To Watch Right Now: General American Investors, Inc.(GAM)

Advisors’ Opinion:

  • [By Max Byerly]

    Gambit (CURRENCY:GAM) traded 7.4% lower against the US dollar during the 1 day period ending at 15:00 PM ET on September 4th. One Gambit token can now be purchased for about $4.78 or 0.00064993 BTC on popular exchanges. Gambit has a market cap of $5.52 million and $2,335.00 worth of Gambit was traded on exchanges in the last 24 hours. Over the last week, Gambit has traded 12.6% higher against the US dollar.

  • [By Joseph Griffin]

    Gambit (GAM) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was May 5th, 2015. Gambit’s total supply is 2,599,999 tokens and its circulating supply is 1,154,053 tokens. Gambit’s official Twitter account is @gambitcrypto. The official website for Gambit is www.gambitcrypto.com.

Top High Tech Stocks To Watch Right Now: DoubleLine Opportunistic Credit Fund(DBL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) announced a monthly dividend on Friday, June 1st, Zacks reports. Investors of record on Thursday, June 14th will be paid a dividend of 0.167 per share by the investment management company on Friday, June 29th. This represents a $2.00 dividend on an annualized basis and a yield of 9.41%. The ex-dividend date is Wednesday, June 13th.

  • [By Joseph Griffin]

    Doubleline Opportunistic Credit Fund (NYSE:DBL) declared a monthly dividend on Monday, October 1st, NASDAQ reports. Stockholders of record on Thursday, October 11th will be paid a dividend of 0.167 per share by the investment management company on Wednesday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 9.98%. The ex-dividend date of this dividend is Wednesday, October 10th.

  • [By Max Byerly]

    News headlines about Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) have been trending somewhat positive on Monday, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Doubleline Opportunistic Credit Fund common stock earned a news impact score of 0.04 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 47.2090833571026 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top High Tech Stocks To Watch Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Colonial Trust Advisors decreased its holdings in Energy Select Sector SPDR (NYSEARCA:XLE) by 23.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,094 shares of the exchange traded fund’s stock after selling 1,266 shares during the period. Colonial Trust Advisors’ holdings in Energy Select Sector SPDR were worth $276,000 as of its most recent SEC filing.

  • [By ]

    Markets were mixed on Wednesday and then surged higher in afternoon trading, led by the energy sector as oil prices rose following President Trump’s withdrawal from the Iran nuclear deal. Exxon Mobile (XOM) and Chevron (CVX) led the way, and the Energy Select Sector SPDR Fund  (XLE)  posted solid gains.

  • [By Jim Crumly]

    Energy stocks rallied, with the Energy Select Sector SPDR ETF (NYSEMKT:XLE) up 1.7%. Consumer stocks lost some ground; the SPDR S&P Retail ETF (NYSEMKT:XRT) slipped 0.7%.

  • [By Chris Johnson]

    Yesterday, I recommended SPDR Energy Select Sector ETF (NYSE Arca: XLE) shares as one of the “Best in Breed,” a screaming buy according to my proprietary system.

  • [By Jim Crumly]

    Technology shares led the market, with the Vanguard Information Technology ETF (NYSEMKT:VGT) advancing 1.2%. Crude oil prices moved lower, dragging down the energy sector; the Energy Select Sector SPDR ETF (NYSEMKT:XLE) fell 1.4%.

  • [By ]

    Tech still has the reins when it comes to leadership for this tape, though this looked a bit shaky over the past three days. Trader talk has surfaced about a rotation out of the sector, namely the large-cap names (the FAANGs and the SOX heavyweights), and into financials and energy over the past three days. We’ve seen some of this materialize in that timespan: FB -2%, GOOGL -1.6%, NFLX -1.4%, SOX -1.1%, AAPL -0.8% vs the KBW Bank index (BKX) +2.4%, thanks to the 10-year yield crawling back to 3%, and the energy SPDR ETF (XLE) gaining 1.8% with the crude pullback subsiding.

Best Heal Care Stocks To Invest In Right Now

SG Americas Securities LLC trimmed its holdings in shares of Spire Inc (NYSE:SR) by 70.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,202 shares of the utilities provider’s stock after selling 10,162 shares during the quarter. SG Americas Securities LLC’s holdings in Spire were worth $304,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Advisor Group Inc. increased its position in shares of Spire by 62.0% during the fourth quarter. Advisor Group Inc. now owns 2,635 shares of the utilities provider’s stock valued at $198,000 after acquiring an additional 1,008 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Spire by 52.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,780 shares of the utilities provider’s stock valued at $209,000 after acquiring an additional 955 shares during the last quarter. Parametrica Management Ltd purchased a new stake in shares of Spire during the fourth quarter valued at approximately $222,000. Zeke Capital Advisors LLC purchased a new stake in shares of Spire during the fourth quarter valued at approximately $227,000. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Spire by 42.0% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 4,841 shares of the utilities provider’s stock valued at $364,000 after acquiring an additional 1,433 shares during the last quarter. 81.83% of the stock is owned by institutional investors.

Best Heal Care Stocks To Invest In Right Now: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    News articles about PDC Energy (NASDAQ:PDCE) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PDC Energy earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the energy producer an impact score of 46.6251700229584 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: Ameresco, Inc.(AMRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Ameresco Inc (NYSE:AMRC) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $13.17.

  • [By Max Byerly]

    Ameresco Inc (NYSE:AMRC) has earned an average rating of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $13.17.

Best Heal Care Stocks To Invest In Right Now: Freeport-McMoran, Inc.(FCX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Copper and gold mining giant Freeport-McMoRan Inc. (NYSE: FCX) has taken the first step in transferring control of its massive Grasberg copper mine to the Indonesian government. The company has signed a nonbinding heads of agreement with Indonesia’s state-owned Inalum that ultimately will result in Inalum taking an ownership stake of 51% in world’s largest copper mine.

  • [By ]

    As Caterpillar sank, so too did Cummins Inc. (CMI) , down 4.5%, Cree Inc. (CREE) , down 2.5%, Crane Co. (CR) , down 8% and Freeport McMoRan (FCX) , down 14.5%.

  • [By Rich Smith]

    Shares of copper and gold miner Freeport-McMoRan (NYSE:FCX)were sliding this morning, but don’t be fooled: The news on Freeport today is good, not bad.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Freeport McMoran Inc. (NYSE: FCX) which traded down over 7% at $17.97. The stocks 52-week range is $11.05 to $20.25. Volume was over 24 million compared to the daily average volume of 18 million.

  • [By ]

    “But on days like today you have to look. You have to say that Caterpillar may not have been as articulate as it would have liked and that perhaps they should have explained that they haven’t seen peak revenues, which is how I read it. I think 3M was just trying to temper expectations so they could beat them. Freeport’s (FCX) a political mess.”

  • [By Matthew DiLallo]

    Freeport-McMoRan (NYSE:FCX) is the largest publicly traded copper producer in the world. Because of that, the company unsurprisinglymakes most of its money on copper.

Best Heal Care Stocks To Invest In Right Now: TE Connectivity Ltd.(TEL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TE Connectivity Ltd (NYSE:TEL) was the recipient of some unusual options trading activity on Thursday. Stock investors purchased 1,536 call options on the stock. This represents an increase of 1,296% compared to the typical daily volume of 110 call options.

  • [By Logan Wallace]

    United Capital Financial Advisers LLC boosted its position in TE Connectivity Ltd (NYSE:TEL) by 18.5% during the 1st quarter, HoldingsChannel reports. The fund owned 11,098 shares of the electronics maker’s stock after acquiring an additional 1,736 shares during the quarter. United Capital Financial Advisers LLC’s holdings in TE Connectivity were worth $1,109,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Achmea Investment Management B.V. increased its stake in TE Connectivity Ltd (NYSE:TEL) by 2.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 235,540 shares of the electronics maker’s stock after purchasing an additional 6,726 shares during the quarter. Achmea Investment Management B.V. owned approximately 0.07% of TE Connectivity worth $18,665,000 as of its most recent filing with the Securities and Exchange Commission.

Best Heal Care Stocks To Invest In Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Slate Path Capital LP purchased a new position in Energy Select Sector SPDR (NYSEARCA:XLE) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,500,000 shares of the exchange traded fund’s stock, valued at approximately $101,115,000. Energy Select Sector SPDR accounts for approximately 6.5% of Slate Path Capital LP’s investment portfolio, making the stock its 6th biggest position. Slate Path Capital LP owned about 0.60% of Energy Select Sector SPDR as of its most recent SEC filing.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By Chris Johnson]

    Yesterday, I recommended SPDR Energy Select Sector ETF (NYSE Arca: XLE) shares as one of the “Best in Breed,” a screaming buy according to my proprietary system.

Best Low Price Stocks To Buy Right Now

Protect American jobs by getting tough on China.

That’s the underlying idea behind President-elect Donald Trump’s threat of a 45% tariff against China as a ploy to bring jobs back to America.

Before pursuing that strategy, however, Trump might want to check out what happened when his predecessor tried that.

President Obama slapped a stiff 35% tariff on Chinese tires in 2009 after American companies complained about unfair competition. They said China was flooding America with tires at low prices making it tough for U.S. companies to compete. The tire tariff gradually waned, and finally ended in 2012.

The tariff saved 1,200 U.S. tire jobs, which had been in sharp decline. And U.S. tire production rose after a major decline.

“Over a thousand Americans are working today because we stopped a surge in Chinese tires,” Obama said in his 2012 State of the Union address.

But a study from the Peterson Institute of International Economics found that the tariffs cost Americans in many other ways.

Best Low Price Stocks To Buy Right Now: GTT Communications, Inc.(GTT)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

  • [By ]

    GTT Communications (GTT) : “I think they have a great business model. I say buy, buy, buy.”

    Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”

  • [By Lisa Levin]

    Analysts at KeyBanc upgraded GTT Communications, Inc. (NYSE: GTT) from Sector Weight to Overweight.

    GTT Communications shares fell 0.64 percent to $46.35 in pre-market trading.

Best Low Price Stocks To Buy Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By ]

    Life in the oil industry has been tough since the price of crude oil fell from north of $100 per barrel in 2014 to less than $40 per barrel by the end of 2015. Many small oil exploration and production companies went belly up since they couldn’t turn a profit with such low oil prices. The effects rippled throughout the entire energy sector. As you can see in the chart below, the Energy Select Sector SPDR ETF (NYSE: XLE) tumbled 45% from its 2014 highs to its 2016 lows:

  • [By Ethan Ryder]

    Traders sold shares of Energy Select Sector SPDR Fund (NYSEARCA:XLE) on strength during trading hours on Thursday. $150.97 million flowed into the stock on the tick-up and $236.14 million flowed out of the stock on the tick-down, for a money net flow of $85.17 million out of the stock. Of all stocks tracked, Energy Select Sector SPDR Fund had the 0th highest net out-flow for the day. Energy Select Sector SPDR Fund traded up $0.09 for the day and closed at $73.65

  • [By Todd Shriber, ETF Professor]

    The energy sector has been on a tear in the second quarter. The Energy Select Sector SPDR (NYSE: XLE), the largest energy exchange-traded fund by assets, is higher by 17 percent so far in the quarter while the S&P 500 is about 5.3 percent.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 25% since Sept. 1. The S&P is up a 15% over the same timeframe.

  • [By Jim Crumly]

    Crude oil surged over $70 a barrel after the announcement that the U.S. will exit the Iran nuclear deal. TheEnergy Select Sector SPDR ETF (NYSEMKT:XLE) jumped 2%. Interest on 10-year Treasurys broke through the 3% level, boosting financial shares, with theFinancial Select Sector SPDR ETF (NYSEMKT:XLF) closing up 1.5%.

Best Low Price Stocks To Buy Right Now: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) decreased to 3.45 million shares from the previous 3.50 million. The stock recently traded at $274.50, within a 52-week range of $244.28 to $370.57.

  • [By Chris Lange]

    Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen Inc. (NASDAQ: BIIB). Through this partnership, these companies are planning to tackle and develop novel antisense drug candidates for a broad range of neurological diseases.

  • [By Brian Orelli]

    Drug-developer Biogen (NASDAQ:BIIB) reported a pretty strong earningsincrease in the first quarter. While revenue growth wasn’t as solid, investors appear to be giving management a pass, thanks to its explanations on why slowing first-quarter sales aren’t a sign of future trouble.

  • [By Brian Orelli]

    Data source: Ionis Pharmaceuticals.

    What happened with Ionis Pharmaceuticals this quarter?
    Revenue increased thanks to $41 million in royalties from Biogen’s (NASDAQ:BIIB) sales of Spinraza, up from just $5 million in the year-ago quarter. Because the tiered royalty rates reset each year, the royalties as a percentage of sales will end up being higher in the quarters to come this year. Despite the higher revenue, earnings turned negative on a GAAP (generally accepted accounting principles) basis: Ionis and Akcea Therapeutics (NASDAQ:AKCA) increased spending in preparation for the launch of Tegsedi for hereditary transthyretin amyloidosis (hATTR), and Waylivra for familial chylomicronemia syndrome, a rare disease that causes the buildup of lipids. Ionis is still the majority owner of Akcea, so its financials are incorporated into Ionis’ financials. The Food and Drug Administration pushed back its goal for making a decision on the marketing application for Tegsedi (the new brand name for inotersen) to Oct. 6, 2018. Ionis provided additional data analysis that the FDA needs additional time to review. In April, Ionis signed another deal with Biogen to develop antisense drugs for neurological disorders. In the deal, Ionis gets $1 billion up front, including an equity investment, in exchange for Biogen having first choice of neurology targets on which to exclusively collaborate with Ionis. Biogen is paying for everything beyond the initial discovery stage, with Ionis eligible for royalties and milestone payments as the drugs advance.

    Image source: Getty Images.

Top 10 Value Stocks To Own Right Now

Investment company Harbour Capital Advisors, LLC buys Amazon.com, Alphabet, Intuit, Target, Micron Technology, Eli Lilly and Co, Citizens Financial Group, Alibaba Group Holding, Equifax, Alphabet, sells Gogo, Apple, Vanguard Total Stock Market, Broadcom, PDC Energy during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Harbour Capital Advisors, LLC. As of 2016-12-31, Harbour Capital Advisors, LLC owns 163 stocks with a total value of $135 million. These are the details of the buys and sells.

New Purchases: INTU, TGT, MU, CFG, BABA, EFX, TTM, CRTO, GPK, HDS, Added Positions: AMZN, GOOG, LLY, GOOGL, VBK, CVE, EWW, DY, V, KHC, Reduced Positions: VTI, IWF, SLB, DG, DAL, CVS, LAD, PAGP, SFM, FDX, Sold Out: GOGO, AAPL, AVGO, PDCE, T, ARMK, VWO, NXPI, FANG, WDC,

For the details of Harbour Capital Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Harbour+Capital+Advisors%2C+LLC

These are the top 5 holdings of Harbour Capital Advisors, LLCChevron Corp (CVX) – 57,856 shares, 5.04% of the total portfolio. Shares reduced by 0.69%iShares Russell 1000 Value (IWD) – 43,240 shares, 3.58% of the total portfolio. Shares reduced by 0.8%iShares Russell 1000 Growth (IWF) – 37,853 shares, 2.94% of the total portfolio. Shares reduced by 15.04%JPMorgan Chase & Co (JPM) – 31,329 shares, 2% of the total portfolio. Shares reduced by 1.14%iShares Russell 1000 (IWB) – 20,025 shares, 1.84% of the total portfolio. Shares reduced by 1.96%New Purchase: Intuit Inc (INTU)

Harbour Capital Advisors, LLC initiated holdings in Intuit Inc. The purchase prices were between $105.28 and $118.39, with an estimated average price of $111.97. The stock is now traded at around $123.18. The impact to the portfolio due to this purchase was 0.34%. The holdings were 4,036 shares as of 2016-12-31.

Top 10 Value Stocks To Own Right Now: The ExOne Company(XONE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) rose by 1.6% to 2.38 million shares. About 22.1% of the company’s shareswere short. ExOne’s share price fell by nearly 13% in the two weeks. The stock’s 52-week range is $6.60 to $16.15, and shares closed at $11.11 on Friday, down about 0.7% for the day. Days to cover fell from 17 to 13.

  • [By Peter Graham]

    A long term performance chart shows Voxeljet AGalong with other small cap 3D printing stocks like ExOne Co (NASDAQ: XONE), 3D Systems Corporation (NYSE: DDD) and Stratasys, Ltd (NASDAQ: SSYS) all peaking around 2013-2014, but also showing some signs of life in recent months:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) fell by 1.7% to 1.86 million shares. About 19.8% of the company’s shares were short. ExOne’s share price jumped by about 14.2% in the period. The stock’s 52-week range is $6.72 to $14.43, and shares closed at $10.39 on Wednesday, up about 1.6% for the day. Days to cover rose from eight to 11.

  • [By Peter Graham]

    A long term performance chart shows shares of Stratasys, Ltd along with other small cap 3D printing stocks like 3D Systems Corporation (NYSE: DDD), ExOne Co (NASDAQ: XONE)and Voxeljet AG (NYSE: VJET) all peaking a few years and all showing some signs of stabilization over the past year:

Top 10 Value Stocks To Own Right Now: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

Top 10 Value Stocks To Own Right Now: Transdigm Group Incorporated(TDG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    TransDigm Group (TDG) soared to the top of the S&P 500 today after beating earnings and sales forecasts.

    Agence France-Presse/Getty Images

    TransDigm gained 6.5% to $245.88 today, while the S&P 500 finished little changed at2,293.08.

    TransDigm reported a profit of $2.57, beating forecasts for$2.47, on sales of $814 million, topping the Street consensus for $804.5 million.

    TransDigm’s market capitalization rose to $13.1 billion today from $12.3 billion yesterday.

  • [By Mitchell Clark]

     This firm is not a household name. This Cleveland-based company, in the aerospace parts business, has approximately $12.0 billion in market capitalization on the stock market.

    TransDigm Group Incorporated (NYSE:TDG) doesn’t pay a regular dividend, but often pays out one-time, special dividends. In the past, they’ve been pretty hefty.

    Selling pumps, motors, power systems, and basically anything you can image that’s part of an aircraft, TDG’s been growing its financial results at a good clip.

  • [By Ben Levisohn]

    TransDigm Group (TDG) tumbled to the bottom of the S&P 500 today after Citron Research doubled down on its assertion that the company is a manufacturing version of Valeant Pharmaceuticals International (VRX).

    Agence France-Presse/Getty Images

    TransDigm Groupdropped 4.2% to $231.37, while the S&P 500 rose 0.3% to 2,372.60.

    From Citron’s report on TransDigm:

    Citron predicts that after this report makes its rounds, TransDigms (NYSE:TDG) days of exploiting and deceiving the Federal Government are numbered.

    Valeant Pharmaceuticals has recently hit prices lower than some ever thought was imaginable. As Citron observes today, at $12 per share, that stock is down over 95% from its highs just months prior to Citrons reporting on Philidor. The questions then turn to: How did so many smart people get it so wrong? and When could this possibly happen again?”

    While we are sure there will be many books written on these questions, we can narrow it down to a small checklist. The smart money got Valeant wrong by:

    Disregarding a roiling political climate disrupting “business as
    usual” Underestimating the financial frailty of a roll up Discounting the dangers of a small customer base (PBMs) Putting too much trust in the companys CEO…

    All points in the above checklist apply directly to TransDigm.

    TransDigm Group’s market capitalization fell to $12.2 billion today from $12.8 billion yesterday. It reported net income of $583 million on sales of $3.2 billion in 2016.

  • [By Ben Levisohn]

    TransDigm (TDG) sunk to the bottom of the S&P 500 today after its earnings topped the Street consensus but its guidance disappointed.

    Shares of TransDigm fell 7.1% to $$252.96 today, while the S&P 500 finished little changed.

    TransDigm reported a profit of $3.29 a share, better than the $3.20 expect by analysts, on sales of$875.2 million, below forecasts for $884.26 million. Worse still, the airplane-part manufacturer said it would earn $11.84 to $12.12 a share in fiscal 2017, below forecasts for$12.80.

    TransDigm’s market cap fell to $13.5 billion today, from $14.5 billion on Friday.

  • [By Lee Jackson]

    Transdigm Group Inc. (NYSE: TDG) had a director at the company step in and buy stock in a big way last week. That director purchased a total of 91,000 shares of the stock at prices ranging from $247.16 to $247.89. The total for the trade came in near $22.7 million.The company designs, produces and supplies aircraft components in the United States. Its stock closed trading last Friday at $251.488.

  • [By Lee Jackson]

    Warren Buffett and Berkshire Hathaway were big buyers this week, as they added shares of aircraft components maker Transdigm Group Inc. (NYSE: TDG), forwhich they also serve as a director. Berkshire Hathaway bought 104,967 shares of the stock at prices that ranged from $231.18 to $234.40 per share. The total for the trade came in at a massive $25 million. The shares closed trading last Friday at $240.05, so the timing looks good. The 52-week trading range for the stock is $214.65 to $294.38. The Wall Street consensus price target is pegged at $295.24.

Top 10 Value Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 25% since Sept. 1. The S&P is up a 15% over the same timeframe.

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By Ben Levisohn]

    Shares of ExxonMobil have ticked up 0.1% to $81.89 at 3:17 p.m. today, while Chevron has risen 0.5% to $108.62. The Energy Select Sector SPDR (XLE) has advanced 0.1% to $69.31.

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

Top 10 Value Stocks To Own Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Peter Graham]

    Online travel stock Tripadvisor Inc (NASDAQ: TRIP) reportedQ1 2017 earnings after the market closed on Tuesday with shares up in afterhours /premarket trading. Q1 revenue rose 6% (or 7% on a constant currency basis) to $372 million as hotel revenue grew 4% to $314 million and non-hotel revenue rose 18% to $58 million.Net income was $13 million versus $29 million. Key business metrics cited in the earnings report included:

  • [By Peter Graham]

    A long term performance chart shows Angie’s List basically back to breakeven while other online review stocks like small cap Yelp Inc (NYSE: YELP) and mid cap Tripadvisor Inc (NASDAQ: TRIP) have performed a bit better with mid capacquirer IAC has been a better performer:

  • [By Ben Levisohn]

    TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today, a reversal of yesterday’s big gain following the news thatExpedia (EXPE) would participate in its Instant Booking program.

    Agence France-Presse/Getty Images

    TripAdvisordropped 5.1% to $46.28 today, while the S&P 500 declined 0.3% to 2,265.18.

    In a note published yesterday, SunTrust Robinson Humphrey’s Rodney Hull and team called the announcement a “positive for [the] platform” but worried about the fact that “shopper growth and monetization have been muted.” They explain:

    Ultimately, TripAdvisor is seeking to improve its revenue per shopper which trails its OTA peers who earn 4-5x more per shopper by driving booking and repeat booking activity on their sites. On a positive note, TripAdvisor stated that US trends improved through the third quarter and that transaction revenue and rev/shopper turned positive in October. Further, green shoots in app bookings and vaulted credit cards are noteworthy. However, the dual headwinds of mobile and the IB transition continue to negatively impact financials as well as the “flywheel” for shopper growth and visibility into improving growth remains limited, aside from easing comps. We have a positive view of the company’s longer-term monetization opportunity, but we await further signs of inflection in growth and profitability, which may follow a larger ad campaign. Recall, the company reduced its margin outlook for 2017 on the 3Q call as it will likely look to increase paid marketing spend and invest revenue per shopper gains to restart the flywheel

    TripAdvisor’s market capitalization fell to $6.7 billion today from $7.1 billion yesterday. It reported net income of $198 million on sales of $1.5 billion in 2015.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Value Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Top 10 Value Stocks To Own Right Now: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.

    The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.

    For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.

    Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:

    Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.

    The shares are down 3.3% to $99.31 in recent trading.

Top 10 Value Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Value Stocks To Own Right Now: Paychex Inc.(PAYX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter on Wednesday.

    Paychex posted Q3 earnings of $0.56 per share on revenue of $795.8 million. However, analysts were expecting earnings of $0.54 per share on revenue of $799.0 million.

  • [By Monica Gerson]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Paychex, Inc. (NASDAQ: PAYX) is estimated to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Paychex shares rose 1.10 percent to close at $56.14 on Wednesday.
    Wall Street expects Micron Technology, Inc. (NASDAQ: MU) to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. Micron shares rose 0.76 percent to $13.29 in after-hours trading.
    Pier 1 Imports Inc (NYSE: PIR) reported a wider-than-expected loss for its first quarter and issued a weak outlook. Pier 1 Imports shares dropped 6.07 percent to $5.11 in the after-hours trading session.
    Analysts are expecting McCormick & Company, Incorporated (NYSE: MKC) to have earned $0.74 per share on revenue of $1.06 billion in the latest quarter. McCormick shares fell 0.59 percent to $102.10 in after-hours trading.

    Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion.
    ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion.
    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million.
    Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion.
    McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion.
    Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share.
    Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million.
    Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million.
    Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Monica Gerson]

    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.50 per share on revenue of $751.20 million.

    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.26 per share on revenue of $362.62 million.

  • [By WWW.THESTREET.COM]

    Wednesday brings earnings from General Mills (GIS) , which will likely be disappointing, Paychex (PAYX) , which will likely be good, and an analyst meeting from Cisco Systems (CSCO) , which needs to show investors it still has more growth ahead.

Top 10 Value Stocks To Own Right Now: Grow Solutions Holdings, Inc. (GRSO)

Advisors’ Opinion:

  • [By Javier Hasse]

    Grow Solutions Holdings Inc (OTC: GRSO) acquired Keys Organic and Hydroponic Supply.

    "What we are starting to see here is aggregation in the highly-fragmented hydroponic and grow supply industry. Most of these stores, including Keys Organic and Hydroponic Supply, are typically local or regional — This results in a very fragmented market."
    "We saw this [aggregation] happen with grocery stores, the finance industry, auto dealerships — Bigger names come in. So, instead of Bob's Ford Motor Company (NYSE: F) Dealership or Fred'sGeneral Motors Company (NYSE: GM) outlet, you'll get companies likeAutoNation, Inc. (NYSE: AN) come in, put them under a single brand, consolidate HR and other expenses to develop economies of scale and really help additional bottom line."
    “Another way to look at it is, there's coffee shops all around the world, but there's also Starbucks Corporation (NASDAQ: SBUX), which started locally […] and developed really organically. But, they could just buy the local coffee shop, redesign it to the Starbucks brand, put their name on it… Now they have the distribution network, the backing of Starbucks, Starbucks will take care of their HR, their payroll — It's a more synergistic approach and a really value-add if they can consolidate any level of scale.”

    Elev8 Brands Inc (OTC: VATE) acquired O2 Breathe, LLC, a company supplying portable oxygen bars and aromatherapy inhalers.

Top 10 Low Price Stocks To Own Right Now

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top 10 Low Price Stocks To Own Right Now: LKQ Corporation(LKQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

Top 10 Low Price Stocks To Own Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By William Patalon III]

    In a Private Briefing report in late July, we told you that tiny biotech Inovio Pharmaceuticals Inc. (Nasdaq: INO) had dosed its first patient in a Phase I clinical study to evaluate its synthetic vaccine for the Zika virus.

  • [By Lisa Levin]

    Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were also up, gaining 24 percent to $8.84 following announcement of a clinical study for a HIV vaccine that had nearly 100 percent immune response.

  • [By Ben Levisohn]

    Shares of Inovio Pharmaceuticals(INO) are climbing today after the biotech company announced that it would begin testing a Zika vaccine in Puerto Rico. Maxim’sJason McCarthy andJason Kolbert have the details:

    CREDIT: Alex Wild Published Credit: Alex Wild Alex Wild

    Inovio announced the initiation of a small clinical study (N=160) of its Zika vaccine, GLS-5700 (being developed with GeneOne Life Sciences), in Puerto Rico. It is estimated by the CDC that the Zika virus could infect more than 25% of the population of Puerto Rico by YE16.The study will evaluate safety, immunogenicity and early signs of efficacy in preventing Zika infection. Data are expected in 2017, and if positive, Inovio will discuss with regulators the best path forward.

    In addition, the phase I study of GLS-5700 (N=40) in the U.S. and Canada, which is the first in-human Zika vaccine study, is now fully enrolled. Data evaluating safety and immunogenicity are expected by YE16.

    Conclusion. With the Zika virus spreading, including to the U.S., there remains an urgent need for a vaccine. Inovio continues to demonstrate that the company’s DNA-based vaccine approach is safe and can rapidly transition to human studies.

    Shares of Inovio Pharmaceuticalshave gained 4.3% to $9.24 at 2:50 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.3% to $284.29.

Top 10 Low Price Stocks To Own Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Chris Lange]

    Merck & Co., Inc. (NYSE: MRK) is expected to share its latest quarterly earnings on Friday. The consensus estimates are$0.87 in EPS on $9.74 billion in revenue. Shares were at $62.63 at Fridays close, in a 52-week range of $57.18 to $66.80. The consensus price target is $69.70.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) dropped about 6.6% Monday to post a new 52-week low of $54.41 after closing at $58.24 on Friday. The stock’s 52-week high is $66.80. Volume of around 32 million was about four times the daily average. The drug maker said it had withdrawn its application for approval of a key lung cancer treatment.

  • [By Ben Levisohn]

    Jefferies analyst Jeffrey Holford and aren’t feeling too upbeat about pharmaceutical stocks in 2017, noting that politics, as well as pharmacy benefit managers, could put downward pressure on pricing. Then there are the weakening fundamentals. As a result, they cut their rating Merck (MRK) to Underperform from Hold…

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Ben Levisohn]

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 0.36% at $56.54. The stock’s 52-week range is $53.63 to $66.80. Volume was about 70% below the daily average of around 11.7 million shares. The company had no specific news.

Top 10 Low Price Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By Craig Jones]

    On CNBC's Trading Nation, Andrew Keene of AlphaShark suggested a bearish options strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He noticed that Energy Select Sector SPDR (ETF) broke out above its resistance, but he thinks it's a fake breakout, which is not going to hold. Keene wants to use options to fade the rally. He wants to buy the March 70/67 put spread for $1. The trade breaks even at $69 or 5.19 percent lower and it can maximally make a profit of $2 if the stock drops to $67 or lower.

Top 10 Low Price Stocks To Own Right Now: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top 10 Low Price Stocks To Own Right Now: Albemarle Corporation(ALB)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By Ben Levisohn]

    Albemarle (ALB) soared to the top of the S&P 500 today after beating fourth-quarter earnings and revenue forecasts.

    S. MARTIN/AFP/Getty Images

    Albemarle gained 9.8% to $101.50, while the S&P 500 dipped 0.3% to 2,363.64.

    Baird’s Ben Kallo and team liked what they saw from Albemarle:

    Reiterate Outperform rating after results beat and guidance exceeded estimates. ALB continues to see strong Lithium demand and pricing, expects Refining Solutions to return to earnings growth in 2017 driven by stronger HPC demand, and bolstered its balance sheet with the sale of Surface Treatment. Additionally, although Bromine is expected to be flat y/y, the segment should generate strong FCF for Lithium investment. We expect shares to trade higher as ALB continues to separate itself from specialty chemical comps with leading market positions and strong revenue growth.

    Albemarle’s market capitalization rose to $11.4 billion today from $10.4 billion yesterday.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Low Price Stocks To Own Right Now: Wabash National Corporation(WNC)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of Wabash National Corporation (NYSE:WNC) jumped 10.1% in April, according to data provided by S&P Global Market Intelligence, after the company reported its first-quarter 2017 results.

Top 10 Low Price Stocks To Own Right Now: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Jabil Circuit, Inc. (NYSE: JBL) to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion. Jabil Circuit shares fell 0.83 percent to close at $21.42 yesterday.

  • [By Monica Gerson]

    Jabil Circuit, Inc. (NYSE: JBL) is projected to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion.

    Guess?, Inc. (NYSE: GES) is expected to post its quarterly earnings at $0.58 per share on revenue of $657.59 million.

  • [By Chris Lange]

    And Jabil Inc. (NYSE: JBL) will report its fiscal first-quarter results on Thursday. The consensus estimates are EPS of $0.79 and revenue of $5.5 billion. Shares traded at $27.88 on Friday’s close, in a 52-week range of $21.31 to $31.70. The consensus price target is $32.23.

Top 10 Low Price Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Low Price Stocks To Own Right Now: Unilife Corporation(UNIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unilife Corp (NASDAQ: UNIS) shares dropped 76 percent to $0.295. Unilife reduced its workforce by 51 employees and expects to record charge of $0.6 million.